Etude cas temoins de l&unknown;effet du traitement hormonal substitutif sur le risque primaire cardiovasculaire chez des femmes bien portantes menopausees (A cross-sectional study of the effects of hormone replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women) - G.M. Prelevic, P. Kwong, D.J. Byrne, I.A. Jagroop, J. Ginsburg, D.P. Mikhailidis, Fertil Steril 2002;77(5):945-51

Author： Homasson N.  

Publisher： Elsevier

ISSN： 1297-9589

Source： Gynecology Obstetrique & Fertilite, Vol.30, Iss.11, 2002-11, pp. : 926-927

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

By Prelevic G.M.   Kwong P.   Byrne D.J.   Jagroop I.A.   Ginsburg J.   Mikhailidis D.P.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 945-951

Elsevier

Access to resources Recommend Favorite

Les anomalies des facteurs de la coagulation n&unknown;influencent pas le pourcentage de naissances vivantes chez les femmes aux antecedents d&unknown;avortement spontane a repetition (Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage) - Howard Carp, M.B., B.S., F.R.C.O.G., Mordechai Dolitzky, M.D., Ilan Tur-Kaspa, M.D., and Aida Inbal, M.D, Fertil Steril 2002;78:58-62

By Palle S.  

Gynecology Obstetrique & Fertilite, Vol. 30, Iss. 11, 2002-11 ,pp. : 927-928

Elsevier

Access to resources Recommend Favorite

Il y a des raisons de poursuivre un traitement hormonal substitutif au-dela d&unknown;une duree de 10 ans - H. Rozenbaum Gynecol Obstet Fertil 2002;30:723-733

By Drapier-Faure E.  

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 2, 2003-02 ,pp. : 189-189

Elsevier

Access to resources Recommend Favorite

Traitement hormonal substitutif de la menopause : poursuivre ou arreter la prescription au bout de 10 ans ? - H. Rozenbaum, M. Le et P. Collet Gynecol Obstet Fertil 2002;30:723-739

By Jamin C.  

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 2, 2003-02 ,pp. : 190-191

Elsevier

Access to resources Recommend Favorite

Relations entre le volume ovarien avant stimulation et la reponse ovarienne sous induction de l&unknown;ovulation par gonadotrophines chez des patientes presentant une anovulation de type 2 de l&unknown;OMS (Relationship of baseline ovarian volume to ovarian response in world health organization ii anovulatory patients who underwent ovulation induction with gonadotropins) - A. Lass, A. Vassiliev, G. Decosterd, D. Warne, E. Loumaye Fertil Steril 2002:78;265-269

By Dewailly D.  

Gynecology Obstetrique & Fertilite, Vol. 30, Iss. 12, 2002-12 ,pp. : 1027-1028

Elsevier

Access to resources Recommend Favorite